Geert Cauwenbergh joins RXi as CEO
This article was originally published in Scrip
Executive Summary
RNAi focused biotech, RXi Pharmaceuticals, has appointed Dr Geert Cauwenbergh president and CEO and a member of the board of directors. Dr Cauwenbergh was most recently chair and CEO of Barrier Therapeutics.